Copeptin as a predictor of survival in ventilator associated pneumonia Source: Annual Congress 2009 - Severe sepsis and multiple organ failure Year: 2009
MR-proANP and prognosis of ventilator-associated pneumonia Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia Year: 2009
Do admission glucose levels aid in predicting mortality associated with community-acquired pneumonia? Source: Eur Respir J, 50 (4) 1700307; 10.1183/13993003.00307-2017 Year: 2017
Risk factors of mortality in COPD patients with ventilator associated pneumonia Source: Eur Respir J 2007; 30: Suppl. 51, 50s Year: 2007
MR-proANP predicts 2-year survival in patients admitted for acute exacerbation of COPD Source: Annual Congress 2009 - Exacerbations of COPD: new findings Year: 2009
Pro-atrial natriuretic peptide to predict short-term and long-term mortality in community-acquired pneumonia Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia Year: 2008
Procalcitonin and clinical pulmonary infection score as predictors of stroke associated pneumonia. Source: International Congress 2018 – Critically ill patients: prognostic factors and biomarkers Year: 2018
Copeptin and prognosis of ventilator-associated pneumonia Source: Annual Congress 2008 - Features of hospital-acquired pneumonia, ventilator-associated pneumonia and infection with other pathogens Year: 2008
Mortality and predictors of death in patients with pneumonia requiring mechanical ventilation Source: Eur Respir J 2005; 26: Suppl. 49, 144s Year: 2005
Admission lactate predicts poor prognosis independently of the CRB/CURB-65 scores in community-acquired pneumonia. Source: International Congress 2017 – Update on community acquired pneumonia Year: 2017
Pro-adrenomedullin, pro-atrial natriuretic peptide and procalcitonin levels at admission in patients with community-acquired pneumonia and its correlation with risk scores Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011
Admission glucose concentrations independently predict early mortality in patients with community-acquired pneumonia Source: Eur Respir J 2007; 30: Suppl. 51, 482s Year: 2007
Determining the prognostic value of procalcitonin in ICU patients who developed hospital acquired pneumonia and comparing with sencitive CRP Source: Annual Congress 2009 - Impact of biomarkers in the management of community-acquired pneumonia Year: 2009
Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 groups at risk Source: Eur Respir J 2007; 30: Suppl. 51, 481s Year: 2007
Incidence of ventilator associated pneumonia (VAP) and assessment of serial estimation of procalcitonin levels as a prognostic marker in cases of VAP in a tertiary centre in India Source: Annual Congress 2012 - Scores, biomarkers and risk factors in respiratory infections Year: 2012
Predicting in-hospital death in pneumonic COPD exacerbation via BAP-65, CURB-65 and machine learning Source: ERJ Open Res, 8 (1) 00452-2021; 10.1183/23120541.00452-2021 Year: 2022
Predictive factors of in-hospital mortality of patients with community-acquired pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 352s Year: 2006
Circulating fetuin-A as a biomarker predicting mortality in ICU septic patients Source: International Congress 2017 – Sepsis, infections, ARDS and beyond Year: 2017
Copeptin predicts early clinical deterioration and persistent instability in community-acquired pneumonia Source: Annual Congress 2012 - Prognostic indices in respiratory infections Year: 2012
Assessment of prognostic scores for 30-day mortality prediction in hospitalised patients with health care associated pneumonia (HCAP) Source: Annual Congress 2010 - The prognosis of community-acquired pneumonia: old and new markers of severity Year: 2010